SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as the community debates its recent sharp decline, largely attributed to Bitcoin's slump, while simultaneously buzzing about potential major catalysts like its rumored role in managing "Trump accounts" for children and favorable new regulatory signals for prediction markets.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is surging as CEO Ryan Cohen hints at a "monumental," "transformational" acquisition of an undervalued public consumer company, igniting community speculation about a massive short squeeze and potential market-wide implications. With $9 billion in cash, no debt, and notable backing from investors like Michael Burry, the retail community is "diamond handing" and buzzing about reported market manipulation.

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.

Atossa Therapeutics Inc

Atossa Therapeutics is trending due to its upcoming 1-for-15 reverse stock split, which is fueling widespread community frustration over perceived mismanagement and fears of further dilution; a recent FDA Orphan Drug Designation for Duchenne Muscular Dystrophy, while new, is met with skepticism amid ongoing concerns about the company's long-term strategy.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Walt Disney Co. is trending as its latest Q1 earnings report showcased strong performance in theme parks and a significant profit jump in streaming, along with a planned $7 billion share buyback. Despite the positive news, the stock is seeing a notable decline, leading to widespread investor frustration and debate within the community over its perceived lack of long-term growth and whether the good results were already factored into its valuation.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical (PBM) is actively discussed following recent approval to use its psilocybin product in a Phase IIb clinical trial for cancer patients, coupled with a CEO letter highlighting clinical progress, a strong cash position, and expansion into longevity research. The community is focused on its extremely low float, institutional interest, and the potential for significant volatility amidst ongoing discussions about its share structure.

VenHub Global, Inc. engages in the management of fully autonomous and robotic-operated convenience stores. It is involved in utilizing technologies such as artificial intelligence (AI) and smart inventory management systems for shopping experience of customers. The company was founded by Shahan Ohanessian and Shoushana Ohanessian on January 31, 2023 and is headquartered in Pasadena, CA.

Venhub Global Inc.

Venhub Global Inc. (VHUB) is seeing significant conversation as a newly direct-listed Nasdaq stock, experiencing high volatility and multiple halts, with the community actively discussing its autonomous Smart Store technology and the strategic appointment of a former Amazon Web Services executive for global expansion.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is seeing a dramatic sell-off and extreme volatility following recent CME margin hikes and allegations of market manipulation by major players. While many anticipate further declines, a strong faction of the community views the sharp drop in paper price as a prime accumulation opportunity, citing underlying physical shortages and robust long-term demand fundamentals.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is experiencing intense trading activity following an impressive earnings beat and robust guidance, fueled by soaring demand for NAND flash and enterprise SSDs in the AI sector. This has ignited a fierce debate among traders, with many anticipating continued explosive growth in a memory supercycle, while others warn of an overextended "pump" amidst its extreme price volatility.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as escalating geopolitical tensions, particularly surrounding Trump's Greenland push and new tariff threats, fuel concerns about international confidence in US Treasuries. Community debate intensifies over how a potential hawkish Fed Chair like Kevin Warsh might impact yields amidst persistent inflation and a shift in global bond market dynamics.

Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.

Perspective Therapeutics Inc

Perspective Therapeutics is trending amidst an equity offering perceived to de-risk its platform and strong buyout speculation, following news that a key competitor has exited the targeted radiopharmaceutical oncology space. The community is highly focused on potential institutional positioning, a short squeeze, and the company's promising clinical data and path toward accelerated FDA approval.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nan Fung Trinity HK Ltd. Invests $2.04 Million in Kura Oncology, Inc. $KURA

Nan Fung Trinity HK Ltd. acquired a new stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange...

Brian Powl Sells 6,414 Shares of Kura Oncology (NASDAQ:KURA) Stock

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) insider Brian Powl sold 6,414 shares of Kura Oncology stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of...

Sector Gamma AS Takes $3.88 Million Position in Kura Oncology, Inc. $KURA

Sector Gamma AS acquired a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities...

Kura Oncology (NASDAQ:KURA) Cut to "Strong Sell" at Zacks Research

Zacks Research downgraded Kura Oncology from a "hold" rating to a "strong sell" rating in a research note on Tuesday...

New Strong Sell Stocks for January 21st

CRNT, KURA and CLSDQ have been added to the Zacks Rank #5 (Strong Sell) List on January 21, 2026.

Kura Oncology, Inc. (NASDAQ:KURA) Short Interest Up 37.5% in December

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totaling...

FY2025 EPS Forecast for Kura Oncology Decreased by Analyst

Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - Research analysts at Brookline Capital Management dropped their FY2025 earnings per share (EPS) estimates for Kura Oncology in a report issued on...

Kura Oncology (NASDAQ:KURA) Stock Price Down 6.1% - Here's Why

Kura Oncology (NASDAQ:KURA) Stock Price Down 6.1% - What's Next...

Kura Oncology (NASDAQ:KURA) Shares Gap Up - Here's Why

Kura Oncology (NASDAQ:KURA) Shares Gap Up - Should You Buy...

Kura Oncology, Inc. $KURA Stock Position Lifted by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. grew its position in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 37.6% in the third quarter, according to its most recent 13F filing with the Securities and...

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Current Price	$8.33
Prev Close	$8.12
Open	$8.09
Dividend Yield	0.00%
50-Day Moving Average	$10.20
Beta	1.02
Avg. Volume	1.66M
PE Ratio	-3.28

52-Week High	$12.49
52-Week Low	$5.41
Market Capitalization	$706.58M
EPS (Annual)	-$2.02
Price to Book	2.91
Revenue Per Employee	$280,640.63
Enterprise Value/EBITDA	N/A

KURA
Kura Oncology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KURA News

KURAKura Oncology Inc